Hybrid Architecture for Engineering Magnonic Quantum Networks

Autor: Rusconi, C. C., Schuetz, M. J. A., Gieseler, J., Lukin, M. D., Romero-Isart, O.

Publikováno v: Phys. Rev. A 100, 022343 (2019)

We show theoretically that a network of superconducting loops and magnetic particles can be used to implement magnonic crystals with tunable magnonic band structures. In our approach, the loops mediate interactions between the particles and allow mag

Externí odkaz: http://arxiv.org/abs/1809.04901

Assignment of individual structures from intermetalloid nickel gallium cluster ensembles.

Autor: Muhr M; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany., Stephan J; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany., Staiger L; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany., Hemmer K; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany., Schütz M; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany., Heiß P; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany., Jandl C; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany., Cokoja M; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany., Kratky T; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany., Günther S; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany., Huber D; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany., Kahlal S; Univ Rennes CNRS, ISCR-UMR 6226, F-35000, Rennes, France., Saillard JY; Univ Rennes CNRS, ISCR-UMR 6226, F-35000, Rennes, France., Cador O; Univ Rennes CNRS, ISCR-UMR 6226, F-35000, Rennes, France., Da Silva ACH; São Carlos Institute of Chemistry, University of São Paulo, P. O. Box 780, 13560-970, São Carlos, SP, Brazil., Da Silva JLF; São Carlos Institute of Chemistry, University of São Paulo, P. O. Box 780, 13560-970, São Carlos, SP, Brazil., Mink J; Hungarian Academy of Sciences, Institute of Material and Environmental Chemistry, Research Centre for Natural Sciences, Magyar tudósok körútja 2, H-1117, Budapest, Hungary., Gemel C; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany., Fischer RA; Department of Chemistry and Catalysis Research Center, Technical University of Munich, Lichtenbergstraße 4, D-85748, Garching, Germany. roland.fischer@tum.de.

Publikováno v: Communications chemistry [Commun Chem] 2024 Feb 13; Vol. 7 (1), pp. 29. Date of Electronic Publication: 2024 Feb 13.

Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy.

Autor: Saalfeld FC; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Center for Tumor Diseases, Dresden, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Möller J; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Center for Tumor Diseases, Dresden, Germany., Christopoulos P; Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRC-H), member of the German Center for Lung Research (DZL), Heidelberg, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Wenzel C; National Center for Tumor Diseases, Dresden, Germany; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Rasokat A; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Wang XA; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Vathiotis I; Third Department of Internal Medicine, Sotiria Hospital, National, and Kapodistrian University of Athens, Athens, Greece., König D; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland., Illini O; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Vienna, Austria; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Vienna, Austria., Grohé C; Department of Respiratory Diseases - ELK, Lindenberger Weg 27, 13125 Berlin, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Wiesweg M; West German Cancer Center, Department of Medical Oncology, University Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Wesseler C; Department of Pneumology, Asklepios Tumorzentrum Hamburg, Klinikum Harburg, Hamburg, Germany., Schubart C; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Pelusi N; Institute of Pathology, University Hospital, University of Bonn, Venusberg-Campus 1, Gebäude 62, 53127 Bonn, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Rohde G; Goethe University Frankfurt, University Hospital, Medical Clinic I, Department of Respiratory Medicine, Frankfurt/Main, Germany., Overbeck TR; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen University, Göttingen, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Kirfel J; Institute of Pathology, UKSH Campus Lübeck, University Hospital Schleswig-Holstein, Ratzenburger Allee 160, Haus V50, 23538 Lübeck, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Alt J; Department of Hematology and Medical Oncology, University Medical Center Mainz, Mainz, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Kauffmann-Guerrero D; Division of Respiratory Medicine and Thoracic Oncology, Department of Medicine V, Thoracic Oncology Center Munich, University Hospital, University of Munich (LMU), Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Griesinger F; Department of Hematology and Oncology, Pius Hospital, University Medicine Oldenburg, Oldenburg, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Kulhavy J; Translational Oncology/Early Clinical Trial Unit (ECTU), Bavarian Cancer Research Center, National Center for Tumor Diseases, Comprehensive Cancer Center Mainfranken and University Hospital Würzburg, Würzburg, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Allgäuer M; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Klimova A; Core Unit for Data Management and Analytics, National Center for Tumor Diseases, Dresden, Germany., Schütz M; National Center for Tumor Diseases, Dresden, Germany; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Aust DE; National Center for Tumor Diseases, Dresden, Germany; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Hochmair MJ; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Vienna, Austria; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Vienna, Austria., Rothschild SI; Cantonal Hospital Baden, Department Internal Medicine, Center of Oncology & Hematology, Baden, Switzerland., Syrigos KN; Third Department of Internal Medicine, Sotiria Hospital, National, and Kapodistrian University of Athens, Athens, Greece., Veluswamy R; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States., Michels S; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Stenzinger A; Translational Lung Research Center Heidelberg (TLRC-H), member of the German Center for Lung Research (DZL), Heidelberg, Germany; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany., Jöhrens K; National Center for Tumor Diseases, Dresden, Germany; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; Department for Pathology, Klinikum Chemnitz gGmbH, Chemnitz, Germany., Wermke M; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Center for Tumor Diseases, Dresden, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany. Electronic address: martin.wermke@ukdd.de.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Oct 12; Vol. 213, pp. 115065. Date of Electronic Publication: 2024 Oct 12.

X-ray and gamma imaging with Medipix and Timepix detectors in medical research

Autor: Procz, S., Avila, C., Fey, J., Roque, G., Schuetz, M., Hamann, E.

Publikováno v: In Radiation Measurements August 2019 127

Understanding the Cytomegalovirus Cyclin-Dependent Kinase Ortholog pUL97 as a Multifaceted Regulator and an Antiviral Drug Target.

Autor: Marschall M; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany., Schütz M; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany., Wild M; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany., Socher E; Institute of Anatomy, Functional and Clinical Anatomy, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany., Wangen C; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany., Dhotre K; Institute for Clinical and Molecular Virology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany., Rawlinson WD; Serology and Virology Division, NSW Health Pathology Microbiology, Prince of Wales Hospital, and Schools of Biomedical Sciences, Women's and Children's Health, Medicine and Biotechnology and Biomolecular Sciences, University of New South Wales, High Street, Sydney 2050, Australia., Sticht H; Division of Bioinformatics, Institute of Biochemistry, FAU, 91054 Erlangen, Germany.

Publikováno v: Cells [Cells] 2024 Aug 13; Vol. 13 (16). Date of Electronic Publication: 2024 Aug 13.